Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015674 (
chronic fatigue syndrome
)
2,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In China, moxibustion is reported to be useful and has few side effects for
chronic fatigue syndrome
, but its mechanisms are largely unknown. More recently, the focus has been on the wealth of information supporting stress as a factor in
chronic fatigue syndrome
, and largely concerns dysregulation in the stress-related hypothalamic-pituitary-adrenal axis. In the present study, we aimed to determine the effect of moxibustion on behavioral symptoms in
chronic fatigue syndrome
rats and examine possible mechanisms. Rats were subjected to a combination of chronic restraint stress and forced swimming to induce
chronic fatigue syndrome
. The acupoints Guanyuan (CV4) and Zusanli (ST36, bilateral) were simultaneously administered moxibustion. Untreated
chronic fatigue syndrome
rats and normal rats were used as controls. Results from the forced swimming test, open field test, tail suspension test, real-time PCR, enzyme-linked immunosorbent assay, and western blot assay showed that moxibustion treatment decreased mRNA expression of corticotropin-releasing hormone in the hypothalamus, and adrenocorticotropic hormone and corticosterone levels in plasma, and markedly increased
progranulin
mRNA and protein expression in the hippocampus. These findings suggest that moxibustion may relieve the behavioral symptoms of
chronic fatigue syndrome
, at least in part, by modulating the hypothalamic-pituitary-adrenal axis and upregulating hippocampal
progranulin
.
...
PMID:Moxibustion upregulates hippocampal progranulin expression. 2721 22